Secret Garden of Leukemia

Program konferencji

19 SeptemberFriday

11:00-11:30 — Welcome brunch
11:30-11:40 — Opening ceremony
Welcome (10 min)

Marta Sobas and Wojciech Świstek. Department of Hematology. Collegium Medicum, Medical University of Bydgoszcz, Poland.
11:40-13:20 — Therapy of acute myeloblastic leukemia

Chairs: Agnieszka Wierzbowska, Maria Podolak-Dawidziak, Pau Montesinos, Lidia Gil
Breaking Bad: AML edition (20 min)

Agnieszka Wierzbowska, Medical University of Łódź, Poland.
No Time to …..Bleeding: Hemostatic Disorders in Leukemias (20 min)

Maria Podolak-Dawidziak, Wroclaw Medical University, Poland.
Miracle on APL Street (20 min)

Pau Montesinos, Hospital La Fe, Valencia, Spain.
Past, Present, Future. Cell therapy in AML (20 min)

Lidia Gil, Medical University of Poznań, Poland.
Discussion (20 min)
13:20 – 14:20 — LUNCH
14:20 – 15:40 — How can be AML outcome improved?

Chairs: Michael Dennis, Artur Kowalik, Amin Turky
Genome of Secrets. Uncovering the blastic crisis of MPN and MDS (20 min)

Artur Kowalik, Division of Medical Biology, Jan Kochanowski University, Kielce, Poland.
Trainspotting – the utility of MRD for treatment decision making in AML (20 min)

Michael Dennis, The Christie NHS Foundation Trust, Manchester, United Kingdom.
The Matrix of Leukemia: When AI sees the Truth. International testing and refinement of an AI algorithm to predict acute leukemia - subtypes from routine laboratory data (20 min)

Amin Turky, Essen, Germany, HARMONY.
Discussion (20 min)
15:40 – 16:00 — COFFEE BREAK
16:00 – 17:40 — Chronic myeloid leukemia

Chairs: Tomasz Sacha, Joanna Góra-Tybor, Sebastian Szmit, Laura Li Gagnon
Chronic myelocytic leukemia: Mission Possible – Evolving Goals and Strategies for CML Therapy (20 min)

Tomasz Sacha, Jagiellonian University, Krakow, Poland.
The blastic phase of CML rises – How to treat refractory/resistant and blastic phase of CML? (20 min)

Joanna Góra-Tybor, Medical University of Łódź, Poland.
Doctor Heart: a cardiology story in CML (20 min)

Sebastian Szmit, Head, Department of Cardio-Oncology CMKP, Warsaw, Poland.
MPN with concomitant CML: Dawn of Coexistance (20 min)

Laura Li Gagnon, Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Discussion (20 min)
17:40 – 18:00 — COFFEE BREAK
18:00 – 19:20 — From bench to patient

Chairs: Claire Harrison, Marta Sobas, Pau Montesinos, Agnieszka Wierzbowska
The English (NHS) Patient...... and nurses. The Nurses role in the management of MPN patients (20 min)

Claire Woodley, Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Interactive clinical case studies – part 1
- Case 1
- Case 2
- Case 3
- Case 4
20:00 — DINNER (Still to be announced)

20 SeptemberSaturday

08:00 – 10:00 — MDS and MPN: blastic transformation

Chairs: Krzysztof Mądry, Claire Harrison, Tata Nageswara Rao, Krzysztof Lewandowski, Patryk Sobieralski
Shakespeare in hematology: MDS or AML, that’s the question (20 min)

Krzysztof Mądry, Warsaw Medical University, Poland.
Inception. Are we able to modify the disease? Can we prevent MPN progression? (20 min)

Claire Harrison, Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, United Kingdom.
The eroded stem cell garden of myelofibrosis – novel diagnostic pathfinders and therapeutic uprooters (20 min)

Tata Nageswara Rao, Department of Oncology and Hematology, Medical Research Center, Cantonal Hospital St. Gallen, Switzerland; Institute for Pharmacology, University of Bern, Bern, Switzerland.
Chronicle of a Death Foretold – blastic phase of MPN (20 min)

Krzysztof Lewandowski, Medical University of Poznań, Poland.
Doubt. Transplant or not to transplant blastic phases of MPN? (20 min)

Patryk Sobieralski, Medical University of Gdańsk, Poland.
Discussion (20 min)
10:00 – 10:20 — COFFEE BREAK
10:20 – 10:40 — Acute lymphoblastic leukemia

Chairs: Adele Fielding, Sebastian Giebel, Jan Styczyński
Hope gap. ALL: is chemotherapy-free treatment a realistic proposition? (20 min)

Adele Fielding, Hull York Medical School, University of York, United Kingdom.
CAR-T and ALL: Avengers Endgame? (20 min)

Sebastian Giebel, Maria Sklodowska-Curie National Oncology Institute, Gliwice, Poland.
Bruce AL(L)mighty: Fighting Pediatric and Adolescence Leukemia (20 min)

Jan Styczyński, Department of Pediatric Hematology and Oncology. Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń.
Discussion (20 min)
11:40 – 13:00 — “Problematic” leukemias

Chairs: Marta Sobas, Irene Navarro Vicente, Guy Pratt
Double lif(n)e of MPAL (20 min)

Marta Sobas, Collegium Medicum, Medical University of Bydgoszcz, Poland.
The curious case of blastic dendritic cell neoplasms (20 min)

Irene Navarro Vicente, Hospital La Fe, Valencia, Spain.
Alien: Plasma cell leukemia (20 min)

Guy Pratt, Cancer Research UK Clinical Trials Unit, University of Birmingham, United Kingdom.
Discussion (20 min)
13:00 – 14:00 — LUNCH
14:00 – 16:40 — Chronic lymphocytic leukemia

Chairs: David Allsup, Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wróbel
Mission (im)possible. Are We Close to a Cure for Chronic Lymphocytic Leukemia? (20 min)

David Allsup, Hull York Medical School, University of Hull, United Kingdom.
Empire Strikes Back? How to treat double-refractory CLL and Richter syndrome (20 min)

Krzysztof Jamroziak, Department of Hematology, Transplantation and Internal Medicine, Warsaw Medical University, Poland.
The outfit – Tailoring Treatment: How the presence of Unmutated IGHV and/or TP53 Mutations Change the Approach to Chronic Lymphocytic Leukemia? (20 min)

Krzysztof Giannopoulos, Department of Experimental Hematooncology, Medical University of Lublin, Poland.
Edge of tomorrow? Investigating the potential of CAR T-cells and bispecific antibodies in CLL (20 min)

Tomasz Wróbel, Wroclaw Medical University, Poland.
Discussion (20 min)
16:40 – 17:00 — COFFEE BREAK
17:00 – 18:00 — From bench to patient

Chairs: to be announced
Interactive clinical case studies – part 2
- Case 1
- Case 2
- Case 3
- Case 4
17:40 – 18:00 — Closing ceremony

Marta Sobas and Wojciech Świstek
19:00 — DINNER (City Hotel restaurant)

21 SeptemberSunday

#MedUpate 2025 BYDGOSZCZ - 21.09.2025

W ramach międzynarodowej konferencji „The secret garden of leukemias”
Podczas konferencji będzie dostępna skrzyneczka na pytania/komentarze chorych

Program

Program konferencji

19 SeptemberFriday

11:00-11:30 — Welcome brunch

11:30-11:40 — Opening ceremony

Welcome (10 min)

11:40-13:20 — Therapy of acute myeloblastic leukemia

Breaking Bad: AML edition (20 min)

No Time to …..Bleeding: Hemostatic Disorders in Leukemias (20 min)

Miracle on APL Street (20 min)

Past, Present, Future. Cell therapy in AML (20 min)

Discussion (20 min)

13:20 – 14:20 — LUNCH

14:20 – 15:40 — How can be AML outcome improved?

Genome of Secrets. Uncovering the blastic crisis of MPN and MDS (20 min)

Trainspotting – the utility of MRD for treatment decision making in AML (20 min)

The Matrix of Leukemia: When AI sees the Truth. International testing and refinement of an AI algorithm to predict acute leukemia - subtypes from routine laboratory data (20 min)

Discussion (20 min)

15:40 – 16:00 — COFFEE BREAK

16:00 – 17:40 — Chronic myeloid leukemia

Chronic myelocytic leukemia: Mission Possible – Evolving Goals and Strategies for CML Therapy (20 min)

The blastic phase of CML rises – How to treat refractory/resistant and blastic phase of CML? (20 min)

Doctor Heart: a cardiology story in CML (20 min)

MPN with concomitant CML: Dawn of Coexistance (20 min)

Discussion (20 min)

17:40 – 18:00 — COFFEE BREAK

18:00 – 19:20 — From bench to patient

The English (NHS) Patient...... and nurses. The Nurses role in the management of MPN patients (20 min)

Interactive clinical case studies – part 1

Case 1

Case 2

Case 3

Case 4

20:00 — DINNER (Still to be announced)

20 SeptemberSaturday

08:00 – 10:00 — MDS and MPN: blastic transformation

Shakespeare in hematology: MDS or AML, that’s the question (20 min)

Inception. Are we able to modify the disease? Can we prevent MPN progression? (20 min)

The eroded stem cell garden of myelofibrosis – novel diagnostic pathfinders and therapeutic uprooters (20 min)

Chronicle of a Death Foretold – blastic phase of MPN (20 min)

Doubt. Transplant or not to transplant blastic phases of MPN? (20 min)

Discussion (20 min)

10:00 – 10:20 — COFFEE BREAK

10:20 – 10:40 — Acute lymphoblastic leukemia

Hope gap. ALL: is chemotherapy-free treatment a realistic proposition? (20 min)

CAR-T and ALL: Avengers Endgame? (20 min)

Bruce AL(L)mighty: Fighting Pediatric and Adolescence Leukemia (20 min)

Discussion (20 min)

11:40 – 13:00 — “Problematic” leukemias

Double lif(n)e of MPAL (20 min)

The curious case of blastic dendritic cell neoplasms (20 min)

Alien: Plasma cell leukemia (20 min)

Discussion (20 min)

13:00 – 14:00 — LUNCH

14:00 – 16:40 — Chronic lymphocytic leukemia

Mission (im)possible. Are We Close to a Cure for Chronic Lymphocytic Leukemia? (20 min)

Empire Strikes Back? How to treat double-refractory CLL and Richter syndrome (20 min)

The outfit – Tailoring Treatment: How the presence of Unmutated IGHV and/or TP53 Mutations Change the Approach to Chronic Lymphocytic Leukemia? (20 min)

Edge of tomorrow? Investigating the potential of CAR T-cells and bispecific antibodies in CLL (20 min)

Discussion (20 min)

16:40 – 17:00 — COFFEE BREAK

17:00 – 18:00 — From bench to patient

Interactive clinical case studies – part 2

Case 1

Case 2

Case 3

Case 4

17:40 – 18:00 — Closing ceremony

19:00 — DINNER (City Hotel restaurant)

21 SeptemberSunday

#MedUpate 2025 BYDGOSZCZ - 21.09.2025